MIT-Northpond Program created to advance innovation in engineering and life sciences
The five-year collaboration aims to accelerate the translation of breakthrough engineering and biology for human health.
The five-year collaboration aims to accelerate the translation of breakthrough engineering and biology for human health.
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
Magdelena Allen is developing a highly sensitive brain PET scanner that can help answer fundamental questions in neuroscience and particle physics.
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
Family trees of lung cancer cells reveal how cancer evolves from its earliest stages to an aggressive form capable of spreading throughout the body.
Fellowship funds graduate studies for outstanding immigrants and children of immigrants.
The system could provide teleoperated endovascular treatment to patients during the critical time window after a stroke begins.
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
The AI-Guided Ultrasound Intervention Device is a lifesaving technology that helps a range of users deliver complex medical interventions at the point of injury.
Improvements in the material that converts X-rays into light, for medical or industrial images, could allow a tenfold signal enhancement.
A new deep-learning algorithm trained to optimize doses of propofol to maintain unconsciousness during general anesthesia could augment patient monitoring.
In the intensity of basic training, a smartwatch-based system warns recruits when they are at risk of heat injury.
The sticky patch could be quickly applied to repair gut leaks and tears.
New fellows are working on electronic health record algorithms, remote sensing data related to environmental health, and neural networks for the development of antibiotics.
A computational study shows that dozens of mutations help the virus’ spike protein evade antibodies that target SARS-CoV-2.